Catalyst Pharmaceuticals Inc

NASDAQ:CPRX   4:00:00 PM EDT
16.46
-0.52 (-3.06%)
7:58:12 PM EDT: $16.32 -0.14 (-0.85%)
Other Pre-Announcement

Catalyst Pharmaceuticals Reports Record Third Quarter 2022 Financial Results

Published: 11/09/2022 21:49 GMT
Catalyst Pharmaceuticals Inc (CPRX) - Catalyst Pharmaceuticals Reports Record Third Quarter 2022 Financial Results and Provides a Corporate Update.
Catalyst Pharmaceuticals Inc Sees FY Revenue $205.0 Million to $210.0 Million.
Catalyst Pharmaceuticals Inc - Product Revenue, Net in Q3 of 2022, Was $57.2 Million, Compared to $35.9 Million.
Catalyst Pharmaceuticals Inc Q3 Revenue Rose 59.3 Percent to $57.2 Million.
Catalyst Pharmaceuticals Inc Q3 Non-GAAP Earnings per Share $0.26.
Catalyst Pharmaceuticals Inc Q3 GAAP Earnings per Share $0.20.